- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07945080
Health Outcomes of CAPABLE in Permanent Supportive Housing
This study will evaluate whether Community Aging in Place-Advancing Better Living for Elders (CAPABLE) improves daily functioning among adults aged 45 years and older who live in permanent supportive housing and have difficulty performing everyday activities.
Participants will be randomly assigned to receive either CAPABLE in addition to their usual services or usual services alone. CAPABLE is a person-directed, home-based program delivered by an occupational therapist and a registered nurse. Participants assigned to CAPABLE may receive up to 10 home visits over approximately six months, including up to six occupational therapy visits and four nursing visits. Assistive devices and minor home modifications may also be provided based on each participant's goals and needs.
The study will enroll approximately 634 participants in Los Angeles County. Researchers will assess participants at enrollment and at 3, 6, 9, and 12 months. The main outcomes are participants' ability to perform activities of daily living and instrumental activities of daily living. The study will also examine health-related quality of life, health care use, housing stability, and the cost-effectiveness of CAPABLE.
Aperçu de l'étude
Statut
Intervention / Traitement
Description détaillée
This randomized effectiveness trial will examine the effectiveness and cost-effectiveness of CAPABLE when delivered to adults living in permanent supportive housing. CAPABLE is a person-directed intervention designed to address functional limitations by integrating occupational therapy, nursing, assistive devices, and minor home modifications.
Approximately 634 participants will be randomly assigned in a 1:1 ratio to the CAPABLE intervention group or the usual-care control group. Participants assigned to CAPABLE will receive the intervention in addition to the health and supportive services normally available to them. The intervention may include up to six occupational therapy visits and four registered nursing visits over approximately six months. The occupational therapist and nurse will work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services will be provided when appropriate. Participants assigned to the control group will continue to receive their usual services.
Study assessments will occur at baseline and at 3, 6, 9, and 12 months. Full outcome assessments will be conducted at baseline, 6 months, and 12 months, with shorter assessments of health care utilization and health-related quality of life at 3 and 9 months. The primary outcomes are limitations in activities of daily living and instrumental activities of daily living. Additional outcomes include health-related quality of life, health care utilization, housing stability, and intervention costs.
Outcome assessors will be masked to participants' treatment assignments. The economic evaluation will compare intervention costs with changes in health-related quality of life and health care utilization to estimate the cost-effectiveness of CAPABLE relative to usual care.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Benjamin F Henwood, PhD, MSW, MA
- Numéro de téléphone: 213-821-0496
- E-mail: bhenwood@usc.edu
Lieux d'étude
-
-
California
-
Los Angeles, California, États-Unis, 90089
- University of Southern California
-
Contact:
- Benjamin F Henwood, PhD
- Numéro de téléphone: 213-821-0496
- E-mail: bhenwood@usc.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Able and willing to provide informed consent
- Client of the Los Angeles County Department of Health Services
- Living in permanent supportive housing
- Age 45 years or older
- Cognitively intact or experiencing only mild cognitive impairment
- Proficient in English or Spanish
- Reports some or a lot of difficulty performing at least one activity of daily living or instrumental activity of daily living
Exclusion Criteria:
- Does not meet one or more inclusion criteria
- Unwilling or unable to provide informed consent
- Withdraws consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: CAPABLE
Participants assigned to this arm will receive CAPABLE in addition to their usual health and supportive services. CAPABLE is a person-directed, home-based intervention delivered over approximately six months and may include up to six occupational therapy visits and four registered nursing visits. Assistive devices, minor home modifications, and coordination with existing services may be provided based on each participant's goals and needs. |
CAPABLE is a person-directed, home-based behavioral intervention designed to improve participants' ability to perform everyday activities. The intervention is delivered over approximately six months and may include up to six visits from an occupational therapist and four visits from a registered nurse. The occupational therapist and nurse work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services may be provided as appropriate based on each participant's goals and needs. |
|
Aucune intervention: Usual Care
Participants assigned to this arm will continue to receive the health and supportive services normally available to them and will not receive the CAPABLE intervention during the study. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Activities of Daily Living Limitations
Délai: Baseline, 6 months, and 12 months
|
Activities of daily living will be assessed using an 8-item scale measuring difficulty with basic daily activities. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms. |
Baseline, 6 months, and 12 months
|
|
Change in Instrumental Activities of Daily Living Limitations
Délai: Baseline, 6 months, and 12 months
|
Instrumental activities of daily living will be assessed using the 8-item Brief Instrumental Functioning Scale. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms. |
Baseline, 6 months, and 12 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality-Adjusted Life Years
Délai: Baseline and 3, 6, 9, and 12 months
|
Health-related quality of life will be measured using the five-item EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Responses will be converted to health-state utility values and used to calculate quality-adjusted life years over the 12-month follow-up period. Higher quality-adjusted life years indicate better health outcomes. |
Baseline and 3, 6, 9, and 12 months
|
|
Health Care Utilization
Délai: Baseline and 3, 6, 9, and 12 months
|
Health care utilization during the preceding three months will be assessed using the 12-item UCSD Healthcare Utilization Questionnaire. Participants will report their use of inpatient hospital care, surgery, nursing home care, emergency department care, ambulance services, outpatient health care, home care, telephone or online health care, prescription medications, and over-the-counter medications. Utilization will be compared between study arms and used to estimate health care costs. |
Baseline and 3, 6, 9, and 12 months
|
|
Incremental Cost-Effectiveness of CAPABLE
Délai: From baseline through 12 months
|
Incremental cost-effectiveness ratios will compare CAPABLE with usual care. Ratios will be calculated by dividing the difference between study arms in intervention and health care costs by the corresponding differences in activities of daily living limitations, instrumental activities of daily living limitations, and quality-adjusted life years. Lower costs per unit of improvement indicate greater cost-effectiveness. |
From baseline through 12 months
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- UP-26-00352
- 1R01AG094859-01A1 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
A deidentified quantitative individual participant dataset will be shared. The study protocol, survey instruments, and data dictionary will also be made available to facilitate interpretation and reuse of the data. The dataset and associated documentation will be deposited in the National Archive of Computerized Data on Aging (NACDA), which is part of ICPSR.
Délai de partage IPD
The IPD and supporting information will become available following completion of the planned study analyses and no later than August 31, 2031. Materials deposited in NACDA will remain available indefinitely.
Critères d'accès au partage IPD
Researchers will be able to access the deidentified individual participant dataset and supporting documentation through NACDA within ICPSR at no charge. Users must agree to the repository's terms of use, including limiting use to research or statistical purposes, not attempting to identify participants, not redistributing downloaded data, and properly citing the dataset.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .